CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502

Journal of Antibiotics

Volumn 55, Issue 10, 2002, Pages 847-854

  Saito, Toshiyuki ^a   Hirai, Hideo ^a   Kim, Yoon Jeong ^a   Kojima, Yasuhiro ^a   Matsunaga, Yasue ^a   Nishida, Hiroyuki ^a   Sakakibara, Tatsuo ^a   Suga, Osamu ^a   Sujaku, Tetsujo ^a   Kojima, Nakao ^a  

^a Nagoya Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ASIMADOLINE; CJ 15208; DELTA OPIATE RECEPTOR; ERINCAINE E; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NORBINALTORPHIMINE; PHENYLALANINE; PROLINE; TETRAPEPTIDE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CTENOMYCES SERRATUS; CULTURE MEDIUM; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSTIMULATION; FERMENTATION; FUNGUS; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; RECEPTOR BINDING; VAS DEFERENS;

CTENOMYCES SERRATUS;

EID: 0036807205     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.55.847     Document Type: Article

References (40)

1. PASTERNAK, G. W.: The opiate receptors. Human Press, Clifton, NJ, 1988
2. PERT, C. B. & S. H. SNYDER: Opiate receptor: demonstration in nervous tissue. Science 179: 1011-1014, 1973
3. PASTERNAK, G. W.; S. R. CHILDERS & S. H. SNYDER: Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 208: 514-516, 1980
4. CHAILLET, P.; A. COULAUD, J.-M. ZAJAC, M.-C. FOURNIE-ZALUSKI, J. COSTENTIN & B. P. ROQUES: The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia. Eur. J. Pharmacol. 101: 83-90, 1984
5. WANG, D. S., G. STERNBACH & J. VARON: Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine. J. Emerg. Med. 16: 471-475, 1998
6. MARTIN, W. R.; C. G. EADES, J. A. THOMPSON, R. E. HUPPLER & P. E. GILBERT: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197: 517-532, 1976
7. LORD, J. A. H.; A. A. WATERFIELD, J. HUGHES & H. W. KOSTERLITZ: Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495-499, 1977
8. WOOD, P. L.; S. E. CHARLESON, D. LANE & R. L. HUDGIN: Multiple opiate receptors: Differential binding of μ, κ and δ agonists. Neuropharmacol. 20: 1215-1220, 1981
9. MANSOUR, A.; H. KHACHATURIAN, M. E. LEWIS, H. AKIL & S. J. WATSON: Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7: 2445-2464, 1987
10. KIEFFER, B. L.; K. BEFORT, C. GAVERIAUX-RUFF & C. G. HIRTH: The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89: 12048-12052, 1992
11. EVANS, C. J.; D. E. KEITH Jr., H. MORRISON, K. MAGENDZO & R. H. EDWARDS: Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992
12. CHEN, Y.; A. MESTEK, J. LIU, J. A. HURLEY & L. YU: Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44: 8-12, 1993
13. FUKUDA, K.; S. KATO, K. MORI, M. NISHI & H. TAKESHIMA: Primary structures and expression from cDNAs of rat opioid receptor δ and μ-subtypes. FEBS Lett. 327: 311-314, 1993
14. WANG, J. B.; Y. IMAI, C. M. EPPLER, P. GREGOR, C. E. SPIVAK & G. R. UHL: μ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90: 10230-10234, 1993
15. YASUDA, K.; K. RAYNOR, H. KONG, C. D. BREDER, J. TAKEDA, T. REISINE & G. I. BELL: Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90: 6736-6740, 1993
16. NISHI, M.; H. TAKESHIMA, K. FUKUDA, S. KATO & K. MORI: cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ-subtype-selective ligands. FEBS Lett. 330: 77-80, 1993
17. MINAMI, M.; T. TOYA, Y. KATAO, K. MAEKAWA, S. NAKAMURA, T. ONOGI, S. KANEKO & M. SATOH: Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329: 291-295, 1993
18. MENG, F.; G.-X. XIE, R. C. THOMPSON, A. MANSOUR, A. GOLDSTEIN, S. J. WATSON & H. AKIL: Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. Natl. Acad. Sci. USA 90: 9954-9958, 1993
19. MOLLEREAU, C.; M. PARMENTIER, P. MAILLEUX, J-L. BUTOUR, C. MOISAND, P. CHALONG, D. CAPUT, G. VASSART & J-C. MEUNIER: ORL1, a novel member of the opioid receptor family. FEBS lett. 341: 33-38, 1994
20. MEUNIER. J-C.; C. MOLLEREAU, L. TOLL, C. SUAUDEAU, C. MOISAND, P. ALVINERIE, J-L. BUTOUR, J-C. GUILLEMOT, P. FERRARA, B. VASSART, M. PARAMENTIER & J. COSTENTIN: Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377: 532-535, 1995
21. ORR, G. F. & H. H. KUEHN: The genus Ctenomyces eidam. Mycopathol. Mycol. Appl. 21: 321-333, 1963
22. BAX, A.: Structure determination and spectral assignment by pulsed polarization transfer via long-range proton-carbon-13 couplings. J. Magn. Reson. 57: 314-318, 1984
23. 3H]U-69593 a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109: 281-284, 1985
24. CALDERON S. N.; R. B. ROTHMAN, F. PORRECA, J. L FLIPPEN-ANDERSON, R. W. MCNUTT, H. Xu, L. E. SMITH, E. J. BILSKY, P. DAVIS & K. C. RICE: Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(αR)-α-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-metoxybenzyl] -N,N-diethylbenzamide (SNC 80): A highly selective, nonpeptide opioid receptor. J. Med. Chem. 37: 2125-2128, 1994
25. BILSKY, E. J., S. N. CALDERON, T. WANG, R. N. BERNSTEIN, P. DAVIS, V. J. HRUBY, R. W. MCNUTT, R. B. ROTHMAN, K. C. RICE & F. PORRECA: SNC80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 273: 359-366, 1995
26. OKA, T.; N. NEGISHI, M. SUDA, T. MATSUMIYA, T. INAZU & M. UEKI: Rabbit vas deferens: a specific bioassay for opioid κ-receptor agonists. Eur. J. Pharmacol. 73: 235-236, 1980
27. BARBER, A.; G. D. BARTOSZYK, H. M. BENDER, R. GOTTSCHLICH, H. E. GREINER, J. HARTING, F. MAULER, K-O. MINCK, R. D. MURRAY, M. SIMON & C. A. SEYFRIED: A pharmacological profile of the novel, peripherally-selective κ-opioid receptor agonist, EMD 61753. Br. J. Pharmacol. 113: 1317-1327, 1994
28. NAQVI, T. & K. B. MATHUR: Structure-activity relationship studies of dynorphin A and related peptides. Peptides 19: 1277-1292, 1998
29. PATERLINI, G.; P. S. PORTOGHESE & D. M. FERGUNSON: Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the κ-opioid receptor. A model for receptor activation. J. Med. Chem. 40: 3254-3262, 1997
30. PORTOGHESE, P. S.; A. W. LIPKOWSKI & A. E. TAKEMORI: Bimorphinans as highly selective, potent κ opioid receptor antagonists. J. Med. Chem. 30: 238-239, 1987
31. PORTOGHESE, P. S.; A. W. LIPKOWSKI & A. E. TAKEMORI: Binaltorphimine and nor-binaltorphimine, a potent and selective κ-opioid receptor antagonists. Life Science 40: 1287-1292, 1987
32. TAKEMORI, A. E.; B. Y. HO, J. S. NAESETH & P. S. PORTOGHESE: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246: 255-258, 1988
33. BOLOGNESI, M.; W. H. OJALA, W. B. GLEASON, J. F. GRIFFIN, F. FAROUZ-GRANT, D. L. LARSON, A. E. TAKEMORI & P. S. PORTOGHESE: Opioid antagonist activity of naltrexone-derived bivalent ligands: Importance of a properly oriented molecular scaffold to guide "address" recognition at opioid receptors. J. Med. Chem. 39: 1816-1822, 1996
34. TESSMER, M. R. & D. A. KALLICK: Role of tryptophan-14 in the interaction of dynorphin A (1-17) with micelles. J. Pept. Res. 49: 427-431, 1997
35. TESSMER, M. R.; J-P. MEYER, V. J. HRUBY & D. A. KALLICK: Structure model of a cyclic dynorphin A analog bound to dodecylphosphocholine micelles by NMR and restrained molecular dynamics. J. Med. Chem. 40: 2148-2155, 1997
36. GUDMUNDSSON, O. S.; G. M. PAULETTI, W. WANG, D. SHAN, H. ZHANG, B. WANG & R. T. BORCHARDT: Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability. Pharm. Res. 16: 7-15, 1999
37. GUDMUNDSSON, O. S.; K. NIMKAR, S. GANGWAR, T. SIAHAAN & R. T. BORCHARDT: Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation. Pharm. Res. 16: 16-23, 1999
38. BAK, A.; O. S. GUDMUNDSSON, G. J. FRIIS, T. J. SIAHAAN & R. T. BORCHARDT: Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers. Pharm. Res. 16: 24-29, 1999
39. SAITO, T.; F. AOKI, H. HIRAI, T. INAGAKI, Y. MATSUNAGA, T. SAKAKIBARA, S. SAKEMI, Y. SUZUKI, S. WATANABE, O. SUGA, T. SUJAKU, A. A. SMOGOWICS, S. J. TRUESDELL, J. W. WONG, A. NAGAHISA, Y. KOJIMA & N. KOJIMA: Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J. Antibiotics 51: 983-990, 1998
40. HAYASHI, T. & T. SASAGAWA: A method for identifying the carboxy terminal amino acid of a protein. Anal. Biochem. 209: 163-168, 1993